Multiple Sclerosis and Headache Co-morbidity. A Case-control Study

Overview

Journal Neurol Sci

Specialty Neurology

Date 2007 Jul 3

PMID 17603764

Citations 25

Authors

G Vacca

E Marano

V Brescia Morra

R Lanzillo

M De Vito

E Parente

G Orefice

Affiliations

Soon will be listed here.

Abstract

The prevalence of primary headache (PH) in a multiple sclerosis (MS) sample vs. control healthy subjects was investigated at a neurological clinic in 2004-2005: 122 of 238 (51%) MS patients and 57 of 238 (23%) controls proved to be affected by headache. The groups did not differ for the rates of PH types. Headache types of MS patients were comparable to those of PH patients that were observed at the same institute in a case-control comparison. First symptoms of headache preceded those of MS in two thirds of cases. Headache features did not significantly change after MS onset. Comorbidity of MS and PH could be explained by some common clinical and biological traits.

Citing Articles

Thunderclap headache as a first manifestation of acute disseminated encephalomyelitis: case report and literature review.

Cicek A, De Temmerman L, De Weweire M, De Backer H, Buyle M, Clement F BMC Neurol. 2024; 24(1):315.

PMID: 39232678 PMC: 11373465. DOI: 10.1186/s12883-024-03803-z.

Headache in Multiple Sclerosis: A Narrative Review.

Adamczyk B, Morawiec N, Boczek S, Danda K, Herba M, Spyra A Medicina (Kaunas). 2024; 60(4).

PMID: 38674218 PMC: 11052044. DOI: 10.3390/medicina60040572.

Headache and Other Pain Syndromes in Multiple Sclerosis: A Narrative Review.

Sirbu C, Rotaru A, Antochi F, Plesa A, Manole A, Roceanu A Life (Basel). 2024; 14(1).

PMID: 38255702 PMC: 10817285. DOI: 10.3390/life14010087.

Immunologic aspects of migraine: A review of literature.

Salahi M, Parsa S, Nourmohammadi D, Razmkhah Z, Salimi O, Rahmani M Front Neurol. 2022; 13:944791.

PMID: 36247795 PMC: 9554313. DOI: 10.3389/fneur.2022.944791.

Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine.

Silvestro M, Tessitore A, Orologio I, Sozio P, Napolitano G, Siciliano M J Clin Med. 2021; 10(24).

PMID: 34945208 PMC: 8708794. DOI: 10.3390/jcm10245914.

References

Munno I, Marinaro M, Bassi A, Cassiano M, Causarano V, Centonze V . Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache. 2001; 41(8):764-7. DOI: 10.1046/j.1526-4610.2001.01140.x. View

Watkins S, Espir M . Migraine and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1969; 32(1):35-7. PMC: 493382. DOI: 10.1136/jnnp.32.1.35. View

Beebe A, Cua D, De Waal Malefyt R . The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 2002; 13(4-5):403-12. DOI: 10.1016/s1359-6101(02)00025-4. View

Freedman M, Gray T . Vascular headache: a presenting symptom of multiple sclerosis. Can J Neurol Sci. 1989; 16(1):63-6. DOI: 10.1017/s0317167100028523. View

De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L . Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003; 33(2):192-6. DOI: 10.1038/ng1081. View

McDonald W, Compston A, Edan G, Goodkin D, Hartung H, Lublin F . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1):121-7. DOI: 10.1002/ana.1032. View

Gee J, Chang J, Dublin A, Vijayan N . The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache. 2005; 45(6):670-7. DOI: 10.1111/j.1526-4610.2005.05136.x. View

Wulff H, Calabresi P, Allie R, Yun S, Pennington M, Beeton C . The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest. 2003; 111(11):1703-13. PMC: 156104. DOI: 10.1172/JCI16921. View

Rosati G . The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001; 22(2):117-39. DOI: 10.1007/s100720170011. View

10.

. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 Suppl 1:9-160. DOI: 10.1111/j.1468-2982.2003.00824.x. View

11.

Ophoff R, Terwindt G, Vergouwe M, van Eijk R, Oefner P, Hoffman S . Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996; 87(3):543-52. DOI: 10.1016/s0092-8674(00)81373-2. View

12.

Haas D, Kent P, Friedman D . Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache. 1993; 33(8):452-5. DOI: 10.1111/j.1526-4610.1993.hed3308452.x. View

13.

Rolak L, Brown S . Headaches and multiple sclerosis: a clinical study and review of the literature. J Neurol. 1990; 237(5):300-2. DOI: 10.1007/BF00314746. View

14.

Pollmann W, Erasmus L, Feneberg W, Then Bergh F, Straube A . Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology. 2002; 59(4):636-9. DOI: 10.1212/wnl.59.4.636. View

15.

Waxman S . Acquired channelopathies in nerve injury and MS. Neurology. 2001; 56(12):1621-7. DOI: 10.1212/wnl.56.12.1621. View

16.

DAmico D, La Mantia L, Rigamonti A, Usai S, Mascoli N, Milanese C . Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia. 2004; 24(11):980-4. DOI: 10.1111/j.1468-2982.2004.00790.x. View

17.

Stewart W, Lipton R, Liberman J . Variation in migraine prevalence by race. Neurology. 1996; 47(1):52-9. DOI: 10.1212/wnl.47.1.52. View